QA: Allergan Finance LLC in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000884629_2013_Allergan_Finance_LLC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Similarly named company. Duplicate? None {'details': [{'other_company': 'Allergan INC', 'shared_tokens': {'allergan'}}]}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000884629, Allergan Finance LLC

  xvar xval
0 AssetsCurrent 3,879,700,000
1 IntangibleAssetsNetIncludingGoodwill 8,592,100,000
2 PropertyPlantAndEquipmentNet 1,479,800,000
3 remainder_Assets 151,900,000
4 LiabilitiesCurrent 2,710,600,000
5 LiabilitiesNoncurrent 162,600,000
6 remainder_Liabilities 7,373,900,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 624,800,000
9 ResearchAndDevelopmentExpense 401,800,000
10 remainder_Expenses 4,714,300,000
11 remainder_Revenues 5,914,900,000
12 remainder_NetIncome -75,700,000
13 remainder_ComprehensiveNetIncome 112,300,000
  yvar yval
0 Assets 14,103,500,000
1 Liabilities 10,247,100,000
2 Expenses 5,740,900,000
3 Revenues 5,914,900,000
4 StockholdersEquity 3,856,400,000
5 NetIncome 98,300,000
6 ComprehensiveNetIncome 154,450,000
7 BaseVar 18,097,200,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.703
9 EconomicCapitalRatio 2.06

Edgar->Model Mapping

Feature Distribution

Change over Time